Position in GRAL
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$682
+$166 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#328
of 371 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GILL CAPITAL PARTNERS, LLC holds $74,966 across 8 Diagnostics & Research names. GRAL ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
226 | $43,048 | |
| 2 | ILMN |
Illumina, Inc.
|
64 | $11,253 | |
| 3 | DGX |
Quest Diagnostics Inc
|
50 | $10,597 | |
| 4 | NEO |
Neogenomics Inc
|
345 | $5,033 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
7 | $3,685 | |
| 6 | GRAL |
GRAIL, Inc.
This page
|
10 | $682 | |
| 7 | WAT |
Waters Corp /De/
|
1 | $375 | |
| 8 | BDSX |
Biodesix Inc
|
13 | $293 |
All Filings in GRAL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $682 | 10 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $516 | 10 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||